menu
    • menu

    Company profile for Aquestive Therapeutics

    NEW Drugs in Dev: 10
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Aquestive Therapeutics (formerly MonoSol Rx) is a specialty pharmaceutical company that advances and commercializes medicines to solve critical healthcare problems and meaningfully improve people’s lives. Our team asks questions and identifies issues others have not, and builds solutions that empower patients and their caregivers with better ways to manage complex diseases. Our initial focus, supported by our current appro...
    Aquestive Therapeutics (formerly MonoSol Rx) is a specialty pharmaceutical company that advances and commercializes medicines to solve critical healthcare problems and meaningfully improve people’s lives. Our team asks questions and identifies issues others have not, and builds solutions that empower patients and their caregivers with better ways to manage complex diseases. Our initial focus, supported by our current approved products and late stage pipeline, is to address immediate CNS challenges.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Aquestive TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    30 Technology Drive Warren, NJ 07059
    Telephone
    Telephone
    908-941-1900
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://aquestive.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/aquestive/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CGT Asia

    Not Confirmed

    envelop Contact Supplier

    CGT Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aquestive Announces Completion of Meeting with FDA for Anaphylm
    Aquestive Announces Completion of Meeting with FDA for Anaphylm

    30 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/30/3264495/0/en/Aquestive-Therapeutics-Announces-Completion-of-Type-A-Meeting-with-FDA-for-Anaphylm-dibutepinephrine-Sublingual-Film.html

    GLOBENEWSWIRE
    30 Mar 2026
    Share Share
    Aquestive Therapeutics Elevates Braender, Names Zalewski as CFO
    Aquestive Therapeutics Elevates Braender, Names Zalewski as CFO

    20 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/20/3259658/0/en/Aquestive-Therapeutics-Announces-New-Role-of-Lori-J-Braender-and-Appointment-of-Thomas-A-Zalewski-as-Chief-Legal-Officer-and-Chief-Compliance-Officer.html

    GLOBENEWSWIRE
    20 Mar 2026
    Share Share
    Aquestive Grants Inducement Under Nasdaq Rule 5635(c)(4)
    Aquestive Grants Inducement Under Nasdaq Rule 5635(c)(4)

    09 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/09/3252280/0/en/Aquestive-Therapeutics-Announces-Grant-of-Inducement-Award-Pursuant-to-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    09 Mar 2026
    Share Share
    Robbins Alerts Investors On Aquestive Class Action
    Robbins Alerts Investors On Aquestive Class Action

    06 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-06/investor-notice-robbins-llp-informs-investors-of-the-aquestive-therapeutics-inc-class-action-laws

    PHARMIWEB
    06 Mar 2026
    Share Share
    Aquestive Reports Q4 & FY25 Results and Provides Business Update
    Aquestive Reports Q4 & FY25 Results and Provides Business Update

    04 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/04/3249714/0/en/Aquestive-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    04 Mar 2026
    Share Share
    Aquestive Therapeutics Joins March Investor Conferences
    Aquestive Therapeutics Joins March Investor Conferences

    25 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/25/3244447/0/en/Aquestive-Therapeutics-to-Participate-in-Upcoming-March-Investor-Conferences.html

    GLOBENEWSWIRE
    25 Feb 2026
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search